Enhanced chemoimmunotherapy of breast cancer in mice by apolipoprotein A1-modified doxorubicin liposomes combined with interleukin-21
出版年份 2023 全文链接
标题
Enhanced chemoimmunotherapy of breast cancer in mice by apolipoprotein A1-modified doxorubicin liposomes combined with interleukin-21
作者
关键词
-
出版物
JOURNAL OF DRUG TARGETING
Volume -, Issue -, Pages 1-13
出版商
Informa UK Limited
发表日期
2023-11-01
DOI
10.1080/1061186x.2023.2276664
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Capsaicin induces redox imbalance and ferroptosis through ACSL4/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells
- (2022) Ceyhan Hacioglu et al. METABOLIC BRAIN DISEASE
- Tumor-associated neutrophils and neutrophil-targeted cancer therapies
- (2022) Haiying Que et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
- (2022) Yanyan Xu et al. Acta Pharmaceutica Sinica B
- APOA1: a Protein with Multiple Therapeutic Functions
- (2021) Blake J. Cochran et al. Current Atherosclerosis Reports
- Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
- (2021) Duopeng An et al. MOLECULES
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
- (2021) Sima Singh et al. DRUG DISCOVERY TODAY
- Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects
- (2021) Alessandro Rizzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond
- (2021) Alessandro Rizzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells
- (2020) Márcia Cristina Oliveira da Rocha et al. JOURNAL OF NANOBIOTECHNOLOGY
- Citrinin exposure disrupts organelle distribution and functions in mouse oocytes
- (2020) Ming-Hong Sun et al. ENVIRONMENTAL RESEARCH
- Recent therapeutic trends and promising targets in triple negative breast cancer
- (2019) Soo-Yeon Hwang et al. PHARMACOLOGY & THERAPEUTICS
- Combining conventional therapy with immunotherapy: A risky business?
- (2019) A. Coosemans et al. EUROPEAN JOURNAL OF CANCER
- The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
- (2019) Warren J. Leonard et al. IMMUNITY
- Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
- (2019) Wei-Di Yu et al. CANCER LETTERS
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing
- (2019) Isabel Prager et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
- (2019) Xuyao Zhang et al. Journal for ImmunoTherapy of Cancer
- Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
- (2018) Xuyao Zhang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma
- (2018) Xuyao Zhang et al. CARCINOGENESIS
- Advances in the systemic treatment of triple-negative breast cancer
- (2018) J.M. Lebert et al. Current Oncology
- Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
- (2018) Tao Shi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within
- (2018) Sarina Kajani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
- (2018) Eric M. Mastria et al. JOURNAL OF CONTROLLED RELEASE
- IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I–Deficient Tumors
- (2018) Hyungseok Seo et al. Cancer Immunology Research
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma
- (2018) Tong-Fei Li et al. BIOMATERIALS
- Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3 inflammasome activation and caspase-1-dependent pyroptosis
- (2018) Xuyao Zhang et al. Nanoscale
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up
- (2018) Sylvia Adams et al. JAMA Oncology
- Tumor Microenvironment and Differential Responses to Therapy
- (2017) Eishu Hirata et al. Cold Spring Harbor Perspectives in Medicine
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
- (2017) Xuyao Zhang et al. Cancer Immunology Research
- IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
- (2016) Elizabeth L. McMichael et al. CLINICAL CANCER RESEARCH
- Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells
- (2016) Fangrong Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis
- (2016) Alice Valentin-Torres et al. Journal of Neuroinflammation
- Interleukin 21 – its potential role in the therapy of B-cell lymphomas
- (2016) Shruti Bhatt et al. LEUKEMIA & LYMPHOMA
- Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
- (2016) Linda K. Mooberry et al. Frontiers in Pharmacology
- Cancer immunotherapy: Strategies for personalization and combinatorial approaches
- (2015) Vishwanath Sathyanarayanan et al. Molecular Oncology
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Dok1 and Dok2 proteins regulate natural killer cell development and function
- (2014) Javier Celis‐Gutierrez et al. EMBO JOURNAL
- Human Peripheral Neutrophils Express Functional IL-21 Receptors
- (2014) Yuji Takeda et al. INFLAMMATION
- Interleukin-21: a double-edged sword with therapeutic potential
- (2014) Rosanne Spolski et al. NATURE REVIEWS DRUG DISCOVERY
- IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells
- (2013) Saskia JAM Santegoets et al. Journal of Translational Medicine
- Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria
- (2013) Nana O. Wilson et al. PLoS One
- Mechanisms and management of doxorubicin cardiotoxicity
- (2011) Y. Shi et al. HERZ
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started